Tomorrow's Bio Today
Princess Anne
About Tomorrow's Bio Today
Tomorrow's Bio Today uses single and multi-camera ingestible tablets that transmit the images captured by the cameras to an application on mobile devices to provide a more cost-effective, safer, and in-depth look into large animal GI tracts than traditional colonoscopies/endoscopies on large animals.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $25.0K
- Funding stage: Seed
- Last round: Pre-Seed (Jan 2024)
- Website: tomorrowsbiotoday.com
- Phone: [email protected]
Industries & Categories
Mobile Devices, Visual Search
Canonical: https://fsome.com/organization/tomorrow-s-bio-today-135842 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.